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ABSTRACT
Objective: Periodontitis is an infection that involved tooth-supporting tissues by dental plaque biofilm on the tooth surface and host immune response 
as causal to as inflammation resolution. Prostaglandin E2 (PGE2) as an inflammatory mediator has been implicated in the pathogenesis of various 
chronic inflammatory diseases, including periodontitis, and as a regulator of blood pressure. This study aims to compare the levels of prostaglandin 
in the gingival crevicular fluid (GCF) of periodontitis patients with hypertension and non-hypertension.
Methods: A total sample of 62 patients was examined and consists of 44 patients (aged 50–90 years) who were hypertension group and 18 patients 
(aged 30–49 years) who were non-hypertension groups as a control. Hypertension state was measured by blood pressure based on anamnesis 
and using sphygmomanometer mercury. The clinical sample was collected from 62 gingival crevicular fluids [GCF] of periodontal disease subject. 
Measurement of the clinical parameter of probing pocket depth [PD], and bleeding on probing [BOP ≥1] was included as a diagnostic requisition. 
The PD and clinical attachment loss [CAL] was defined as present if the PD was ≥5 mm and CAL was ≥1 mm. Prostaglandin E2 level was estimated in 
gingival crevicular fluid samples by using the enzyme-linked immunosorbent assay.
Results: The level of PGE2 was statistically significant difference in hypertension patient compare with non-hypertension (p<0.05). There was a 
significant difference in PD, recession, and CAL (p<0.05).
Conclusion: Higher blood pressure might be related to the potential risk of inflammation and progression periodontal disease. 
Keywords: Prostaglandin E2, Periodontitis, Hypertension, Inflammation.
INTRODUCTION
Life expectation was increased in a person who is seen in older adult 
populations in developing countries. Among the potential targets for 
improving the health of older adults, hypertension represents one of 
the most prevalent and potentially modifiable conditions. Hypertension 
remains a major worldwide problem and is a condition that is often 
diagnosed in primary health care. In 2008, approximately 40% of adults 
aged ≥25 years were diagnosed with hypertension worldwide [1]. This 
number has increased in recent years from 600 million people in 1980 
to a billion people in 2008 [1]. The highest prevalence of hypertension 
was found in the African region, which was estimated at 46% in adults 
aged ≥25 years, whereas the lowest prevalence was found in the 
United States of America at 35% [2]. A study mentioned that cases of 
hypertension that have been diagnosed by health personnel or people 
taking anti-hypertension drugs remain low in Indonesia at 24.2%, 
suggesting that 75.8% of hypertension cases in the community have 
not been identified by the health service [3]. Ideally, the normal blood 
pressures are 120/80 mmHg. Hypertension is defined if individuals 
have blood pressures ≥140/90 mmHg [3].
Periodontal disease is a chronic inflammatory disease resulted in 
progressive destruction in the supporting structures of teeth which are 
the gingiva, periodontal ligament, cementum, and alveolar bone, and is 
caused by interactions between bacteria and host immune system [4]. 
Lipopolysaccharides produced by bacteria trigger the production of 
tumor necrosis factor-alpha, interleukin-1ß, and prostaglandin E2 
(PGE2) from macrophages, fibroblasts, and inflammatory cells in 
periodontal tissues [4]. The activity of inflammatory responses and the 
associated molecules can cause damage to the tissue and alveolar bone. 
The development of the advanced periodontal disease can result in 
clinically periodontal pocket formation, changes in height and density 
of subjacent alveolar bone, and recession of the marginal gingiva also 
present [4]. Continued bleeding with probing during sequential visits 
has proved to be a reliable indicator of the presence of inflammation 
and increased risk for progression of attachment loss at the bleeding 
site [4,5].
Periodontal disease has a potential relationship with cardiovascular 
disease because there was a possible association in chronic 
inflammatory conditions with systemic markers of inflammation and 
endothelial dysfunction. There were several research studies suggested 
a possible relationship between chronic inflammation and hypertension. 
Holmlund et al. reported a relation between periodontal disease severity 
and hypertension [6]. Contradictory, the study analysis of the Health 
Professionals Follow-Up Study did not show any significant associations 
between periodontal disease and hypertension diagnosis over 20 years 
of follow-up [7]. The Third National Health and Nutrition Examination 
Survey data result did not show any association between the severity of 
periodontal disease and blood pressure measurement [8].
PGE2 is the dominant prostanoid of arachidonic acid (AA) and involved 
in various biological systems such as the cardiovascular, endocrine, 
gastrointestinal, neural, and reproductive systems; it is also involved 
in the regulation of blood pressure through vasodepressor and/or 
vasopressors. PGE2 has subtype receptors known as E-prostanoid (EP) 
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receptor and divided into four receptors (EP1, EP2, EP3, and EP4) that 
are mediated by G-coupled proteins which encoded by different genes 
and expressed differently in each tissue [9]. The previous studies have 
determined that the EPs expressed differently while particularly the 
EP1 and EP3 receptors mediated the pressor response and the EP2 and 
EP4 receptors mediate the depressor response [9].
PGE2 also plays a role in the pathogenesis of chronic inflammatory 
diseases, including periodontitis. It is a key regulator in the expression 
of the receptor activator of nuclear factor-κB ligand along with IL-6 [10]. 
Several studies stated that PGE2 and IL-6 were increased in patients 
with periodontitis [11]. It participates in the inflammatory response. 
Pro-inflammatory effects of PGE2 are increasing vasodilatation, 
enhancing responsiveness of receptors to painful stimuli, releasing of 
collagenase by inflammatory cells and activation of osteoclast, thereby 
causing bone resorption [12]. PGE2 also plays an important role in blood 
pressure regulation as a vasodepressor or vasopressor in blood vessels. 
This study aims to compare the levels of prostaglandin in the gingival 
crevicular fluid (GCF) of periodontitis patients with hypertension and 
non-hypertension.
METHODS
This study was approved by the Ethics Committee of the Faculty 
of Dentistry of Universitas Indonesia (no. 98/Ethical Approval/
FKGUI/V/2019). Clinical samples were collected from RSKGM 
Universitas Indonesia patients. The laboratory work was conducted at 
the Integrated Laboratory, Faculty of Medicine, Universitas Indonesia.
This work followed an observational study design, in which 62 GCF 
samples from individuals aged between 30 and 90 years (23 men and 
39 women) were collected between February and June 2019. All the 
patients provided written informed consent to participate in this study. 
Complete anamnesis was performed by asking participants about their 
chief complaints, medical history, information about any allergies, 
systemic condition, use of medication, smoking habits, tooth brushing 
habits, etc. Detailed information included extraoral and intraoral 
checks, measuring participant’s oral hygiene index, pocket depth (PD), 
recession, clinical attachment loss (CAL), and bleeding on probing 
(BOP).
The inclusion criteria were patients with periodontitis Stage II and III 
according to the criteria of the World Workshop on the Classification of 
Periodontal and Peri-Implant Diseases and Conditions 2017 [13]. The 
clinical parameters that comprise these criteria are PD ≥4 mm, BOP 
score ≥1, and CAL ≥1 mm. The exclusion criteria were patients with a 
history of bruxism or smoking, intake of drugs during the past 6 months, 
pregnancy or breastfeeding, scaling ≤6 months, or consumption of 
antibiotics ≤3 months. Patients who were not taking medication or 
treatment for hypertension were included in the control group.
Blood pressure was measured using a mercury sphygmomanometer 
more than once when individuals were in a calm state [14]. The blood 
pressure of the patients was measured when they were seated, with 
their elbow bent on the table, palm facing up, and their arm placed 
higher than their heart [15].
Periodontal clinical examinations for BOP and PD were recorded using 
a Periodontal Probe UNC 15 (Osung Mnd, Korea). BOP was recorded 
as local bleeding present 30 s after probing using a scale from 0 to 4 
(from no bleeding to widespread bleeding). Following this examination, 
GCF samples were as collected from each individual after removal of 
the supragingival plaque. GCF was obtained in the study group patients 
with PD ≥4 mm and also from the control group patients.
The tooth surfaces were dried and isolated using cotton rolls. Three 
paper points (no. 25) was inserted into the periodontal pockets and 
held them in place for between 20 and 30 s. The paper points were then 
placed into sterile Eppendorf tubes comprising 200 µl of phosphate-
buffered saline, refrigerated, and immediately transferred to the oral 
biology laboratory for analysis. The Eppendorf tubes comprising the 
samples were stored at −70°C.
The sample was tested by a competitive ELISA principle. The micro-
ELISA plate provided with the kit had been pre-coated with PGE2. 
During the reaction, PGE2 in the sample or the standard competes 
with a fixed amount of PGE2 on the solid phase supporter for 
sites on the biotinylated detection ab 50 µL specific to PGE2 then 
incubated for 45 min at 37˚C. Excess conjugate and unbound sample 
or standard were washed from the plate, avidin conjugated with 
horseradish peroxidase was added to each microplate well in the 
amount of 100 µL, and the microplates were incubated for 30 min 
at 37°C. Next, 3,3′,5,5′-tetramethylbenzidine substrate solution was 
added to each well. The enzyme-substrate reaction was terminated 
by the addition of a stop solution and the color change was measured 
spectrophotometrically at 450±2 nm. The concentration of PGE2 in 
the samples was determined by comparing the optical density of the 
samples using the standard curve.
Statistical analysis
All statistical data analyses were performed using the SPSS software 
program (SPSS, Chicago, USA) with a significance level of 5%. Age, 
plaque index, calculus index, debris index, oral hygiene index, PD, 
recession, CAL, and BOP were expressed by means and standard 
deviation. The data normality was using Kolmogorov–Smirnov stated 
that a total sample was 62 subjects. Data distribution resulted that the 
total sample in the inclusion group used a non-parametric test (p>0.05). 
A Mann–Whitney test was used to compare the level of PGE2 in subjects 
with hypertension and non-hypertension.
RESULTS AND DISCUSSION
A total of 62 participants agreed to retrieve their blood pressure 
status and a single site of the gingival crevicular area inspection. The 
participant’s hypertension state was established with measured 
systolic and diastolic >140/90 mmHg.
Table 1 shows the data distribution on the periodontal parameter of 
the two groups based on blood pressure status (hypertension and non-
hypertension). Plaque index, calculus index, debris index, recession, 
and BOP data were not normally distributed with p>0.05. The mean 
PD was 5.47±1.13 mm (hypertension group) which slightly different 
with 4.33±1.11 mm (non-hypertension group). PGE2 level was higher 
in non-hypertension group 64.66 (20.79) pg/mL than in hypertension 
group 47.35 (17.94) pg/mL.
The comparative test (*Mann–Whitney U-test) in Table 2 showed that 
there were significant differences in the subject of hypertension and 
non-hypertension on statistical levels of PGE2 p=0.002 (p<0.005).
Table 1: Clinical characteristic of the periodontal parameter in 
subject with hypertension and non-hypertension
Hypertension Non-hypertension p value
Mean (SD) Mean (SD)
Sociodemography
Age (years) 70.15 (8.41) 45.72 (12.62) 0.053
Clinical parameter
Plaque index 1.72 (0.82) 1.02 (0.44) 0.163
Calculus index 1.65 (0.92) 1.27 (0.72) 0.181
Debris index 1.25 (0.90) 0.86 (0.45) 0.073
Oral hygiene index 2.97 (1.58) 1.86 (0.86) 0.002
Pocket depth (mm) 5.47 (1.13) 4.33 (1.11) 0.001
Recession (mm) 5.57 (2.9) 1.78 (1.55) 0.001
Clinical attachment 
loss (mm)
10.93 (3.69) 6.06 (2.46) 0.001
Bleeding on probing 1.54 (1.01) 1.26 (0.90) 0.200
PGE2 (pg/mL) 47.35 (17.94) 64.66 (20.79) 0.013
Distribution data test; significant p>0.05
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Comparative analysis of the clinical periodontal parameter in Table 3 
showed that there was a significant difference in index plaque, 
recession, PD, and CAL p=0.01 (p<0.05), but there were no significant 
differences in other clinical periodontal parameters between subjects 
with hypertension and non-hypertension (p>0.05).
Inflammatory mediators in GCF have been considered as biomarkers 
of the progression and severity of periodontitis, as well as indicators of 
response to treatment. In this study, the mean concentration of PGE2 in 
the GCF was lower in the hypertension group than in non-hypertension 
group, Table 1. The previous study population subjects age between 18 
and 77 years old mentioned that PGE2 production seems to be modified 
by age and as the immune response ages, the immune system ages may 
decline as well [16].
The previous studies have evaluated the association between 
periodontal disease and hypertension. So far, little are known about 
the phenomena of this association, Table 3 shows that there was 
a significant difference in clinical periodontal parameter between 
hypertension and non-hypertension group. These results reveal 
with scientific evidence a possible connection between periodontal 
disease and systemic inflammation which in turn is associated with an 
increased risk of hypertension [5]. Contradictory, analysis of the Third 
National Health and Nutrition Examination Survey data result did not 
show any association between the severity of periodontal disease and 
blood pressure measurement [8].
The present study population is older compared to previous 
publications which suggest that local and perhaps consequent systemic 
inflammation might play a greater role in blood pressure control among 
the elderly. The relationship between periodontitis and hypertension 
is pivotal to the progression of cardiovascular disease because it is 
affected by the degree of blood pressure by people with hypertension. 
Existing studies report a variety of measurements of periodontal 
disease and use different definitions of hypertension outcomes [17].
Production of prostaglandin depends on the synthases activity of 
cyclooxygenase (COX), bifunctional enzymes that contain both COX 
and peroxidase [18]. The type of prostanoid production is determined 
by the differential expression of these enzymes within cells present at 
sites of inflammation. During the inflammatory response, inflammatory 
mediators activate the transcription of target genes, such as COX-2 
and mPGES-1, and regulate PGE2 synthesis by activating the NF-κB 
pathway [19]. In chronic inflammation, PGE2 levels in GCF (Table 3) 
showed significant differences with clinical parameters of BOP. PGE2, a 
blood pressure regulator, is a mediator for the inflammatory response 
also involved in gastrointestinal integrity, and it plays a role in fertility. 
However, the involvement of PGE2 in the resolution of inflammation 
has also been suggested [20].
PGE2 is a major mediator in the inflammatory response, blood 
pressure regulator, gastrointestinal integrity, and fertility. During 
the inflammatory response, the inflammatory mediators activate the 
transcription of target genes such as COX-2 and mPGES-1 and regulate 
PGE2 synthesis by activating the NF-κB pathway [21]. However, it has 
also been suggested that PGE2 could be involved in the resolution of 
inflammation [22]. Prostaglandins (PGs) are formed by a sequential 
series of three enzymatic reactions: Release of AA from AA derived 
from phospholipid membranes in phospholipases, conversion of 
AA to an unstable endoperoxide intermediate PGH2 by COX, and 
isomerization prostaglandin H2 becomes bioactive prostanoid 
such as PGE2, prostacyclin, prostaglandin F2, prostaglandin D2, and 
thromboxane A2 by distinct terminal synthases [22]. These findings 
were in line with Table 3 that showed at PD which has significant 
difference statistically.
A previous study by Andrew et al. found that the mean plaque and 
gingivitis scores were higher in patients with gingival overgrowth 
secondary to anti-hypertension agents (than those without gingival 
overgrowth), but there was also no significant difference of mean 
plaque and gingivitis scores between the two groups [23]. This was 
in line with comparative analysis (Table 3) that showed a significant 
difference in PD, recession, and CAL (p<0.05) with Gaetti-Jardim 
et al. study that reported patients with underlying cardiovascular 
disease and chronic periodontitis showed higher mean plaque 
score, probing PD, and CAL compared to periodontally healthy 
subjects [24].
This study has several limitations. Arterial pressure directly 
corresponds to cardiac output, arterial elasticity, and peripheral 
vascular resistance [25]. Blood pressure is remarkably easy to alter 
and can be affected by many activities. In as much as the blood 
pressure measurements were taken on only one occasion, day-
to-day variations in blood pressure may have resulted in random 
misclassification of our outcome measure of high blood pressure. In 
this study, high blood pressure in the patients can be produced by 
PGE2 receptors 1 and 3 [22].
The renin-angiotensin-aldosterone system relies on several hormones 
that act to increase blood volume and peripheral resistance. It begins 
with the production and release of renin from juxtaglomerular cells 
of the kidney. In our study, the functional condition of the kidney was 
not addressed because the evidence that referred to the relationship 
of periodontal disease with the kidney did not show significant 
results [26]. Furthermore, due to a relatively small sample size, there 
was not enough statistical power for some of the subgroup analysis. 
Given the limitations of this study, further studies are needed to confirm 
this association in other populations.




n PGE2 (pg/mL) p value
Median Min–Max
Hypertension 44 51.08 10.16–80.26 0.002
Non-hypertension 18 68.57 9.75–94.79
Mann–Whitney U-test; significant p<0.05
Table 3: Comparative analysis between clinical periodontal parameter in hypertension and non-hypertension
Clinical periodontal parameter Hypertension (n=44) Non-hypertension (n=18) p value
Median Min–Max Median Min–Max
Plaque index 1.65 0.08–3 0.98 0.50–1.70 0.001
Calculus index 1.46 0.11–4.5 1.07 0.38–2.75 0.072
Debris index 1.13 0.00–3 0.65 0.26–2.1 0.138
Oral hygiene index 2.94 0.08–6 1.41 1.01–3.8 0.009
Pocket depth (mm) 5 3–8 4 3–7 0.001
Recession (mm) 5 0–12 1 0–7 0.001
Clinical attachment loss (mm) 10 4–20 6 2–14 0.001
Bleeding on probing 1.38 0.00–4 0.96 0–2.86 0.153
Mann–Whitney U-test; significant p<0.05
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CONCLUSION
PGE2 level in GCF in periodontitis patient with hypertension may indicate 
the risk of severe periodontal disease compares to non-hypertension 
patients. Resolution PGE2 in inflammation such periodontitis may 
increase alveolar bone resorption. Higher blood pressure may have a 
potential risk of periodontal disease. Expression of EP has to further 
investigation of the role in hypertension and periodontal disease. PGE2 
can be one of the markers in seeing periodontal destruction. Further 
studies are needed to confirm the result of this study.
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